The Valley Desk

Clinical trial reportJournal of Crohn's & colitisPublished

Serum protein profiles differ with adalimumab and ustekinumab treatment in moderately to severely active Crohn's disease

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Clinical trial report
Venue
Journal of Crohn's & colitis
Published
Subject terms
Humans; Crohn Disease; Blood Proteins; Anti-Inflammatory Agents; Interleukins; Severity of Illness Index; Double-Blind Method; Adult; Middle Aged; Female; Male; Adalimumab
PubMed ID
41258994
Added to directory
Source checked

Report a correction or request removal